Signifor (pasireotide subcutaneous injection - Novartis) — Cigna

Initial criteria

• Patient is age ≥ 18 years; AND
• Patient meets ONE of the following (i, ii, or iii): i) According to the prescriber, the patient is not a candidate for surgery OR surgery has not been curative; OR ii) Patient is awaiting surgery for endogenous Cushing’s syndrome; OR iii) Patient is awaiting therapeutic response after radiotherapy for endogenous Cushing’s syndrome; AND
• The medication is prescribed by or in consultation with an endocrinologist or a physician who specializes in the treatment of Cushing’s syndrome

Approval duration

1 year